01 1BrightGene Bio-Medical Technology Co.,Ltd
01 1VOCLOSPORIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-19
Pay. Date : 2024-07-11
DMF Number : 39556
Submission : 2024-07-09
Status : Active
Type : II
20
Brightgene Bio-medical Technology Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VOCLOSPORIN, with a corresponding US DMF Number 39556.
Remarkably, this DMF maintains an Active status since its submission on July 09, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 19, 2024, and payment made on July 11, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
